Age-related macular degeneration, characterized by the loss of central vision, affects 1.65 million individuals in the United States and is the leading cause of vision loss in people older than 65 years, according to Friends for Sight, a nonprofit organization dedicated to saving sight.
During February, which is Age-related Macular Degeneration Month, eye care organizations encourage individuals to get regular eye exams with an ophthalmologist to detect possible signs of AMD, as well as remind people with AMD that there are treatments that can save their sight.
Here are five recent articles or videos regarding treatment options and advancements for AMD:
Pixium Vision receives FDA appro
val to begin clinical study of Prima implant
The study will be conducted at the University of Pittsburgh Medical Center and will recruit up to five patients with vision loss from atrophic dry AMD. Read more.
Early detection of AMD integral to achieving best vision long-term
The keys to both achieving and maintaining best vision in patients with neovascular age-related macular degeneration are disease control and early detection, according to a speaker at Retina 2018. Read more.
OCT for personalized anti-VEGF treatments saves US billions
OCT used to guide personalized anti-VEGF treatments for neovascular age-related macular degeneration patients saved the United States $9 billion. Read more.
VIDEO: Gene therapy for retinal disease continues to march forward despite headwinds
Allen C. Ho, MD, of Wills Eye in Philadelphia, discusses the latest updates on research into gene therapy for AMD and other blinding retinal diseases. Watch here.
VIDEO: OCT angiography useful throughout AMD treatment
Nadia K. Waheed, MD, MPH, discusses her use of OCT angiography throughout the diagnosis and treatment of age-related macular degeneration. Watch here.